Proprietary blends on supplement labels: what they actually hide
A proprietary blend on a supplement label is not, by itself, evidence of fraud, but it is a labeling technique that allows clinically meaningless doses to coexist with clinically suggestive marketing. When a product's marketing references a trial-validated ingredient, that ingredient should be listed with a disclosed dose, not buried in a blend. Third-party certified products and single-active-ingredient supplements avoid the issue entirely.
A bottle that lists "Energy Blend 1,200 mg" with ten herbs and amino acids below it is using a labeling technique called a proprietary blend. The total combined weight of the mixture is disclosed, but the dose of each individual ingredient is not. Under the Dietary Supplement Health and Education Act of 1994, this is legal. It is also one of the most useful red flags for evaluating a supplement, because it lets a manufacturer name an impressive-sounding, trial-associated ingredient on the label without committing to—or paying for—a clinically meaningful amount of it.
The legal structure that allows it
FDA's labeling regulation for supplements (21 CFR 101.36) generally requires the Supplement Facts panel to state the quantity per serving of each dietary ingredient. The proprietary-blend provision is the exception: a manufacturer may group ingredients under a fanciful blend name and disclose only the blend's total weight, provided the components are listed in descending order by weight. The practical consequence is that a 1,000 mg blend of ten ingredients can be distributed in almost any internal proportion. Because only descending order is required, a blend can legally place nearly all of its mass in the first one or two ingredients—often the cheap fillers or the caffeine—while the marquee botanical sits near the bottom of the list at a token amount.
Why the hidden dose matters
For most evidence-based ingredients, the effect is dose-dependent, so an undisclosed dose can quietly be a useless one. Creatine is the clearest example: the International Society of Sports Nutrition's position stand identifies creatine monohydrate as effective and describes a maintenance intake on the order of 3 g/day, with higher loading doses used short-term [1]. A pre-workout product that folds "creatine" into a 1,000 mg blend alongside several other ingredients cannot be delivering anything close to that, no matter how prominent the word is on the front of the tub. The same logic applies across categories—amino acids, botanicals, and nootropics all have trial-validated dose ranges that simply do not fit inside a small total-blend weight shared among many ingredients.
Even disclosed numbers are often wrong
The problem is compounded by poor label accuracy in exactly the product categories that lean on blends. A 2021 analysis quantified caffeine in 52 commercial pre-workout supplements and found that, among the 36 products that declared a caffeine amount, 42% contained less than 80% of the labeled quantity and 19% contained more than 120%; six products contained caffeine that was not declared at all [2]. If a measurable, single-compound stimulant is mislabeled this often when its amount is stated, there is little reason to trust the unstated per-ingredient doses buried inside a proprietary blend.
What blends can actually hide
The blend format does not just conceal under-dosing; it can conceal ingredients that should not be there at all. Independent analyses have repeatedly found unapproved and even banned stimulants in supplements marketed for energy, weight loss, and sport. In one laboratory study, products were found to contain banned 1,3-DMAA and 1,3-DMBA along with previously unidentified stimulants—including octodrine at about 72 mg per serving, more than twice the highest dose once used pharmaceutically [3]. A consumer reading the panel sees an exotic-sounding "blend"; a mass spectrometer sees a pharmacologically active drug at an unstudied dose. The opacity of the blend is precisely what makes this possible.
Reading a label without disclosed doses
Two practical signals help. First, the ingredient sequence: components are listed in descending weight order, so the first one or two ingredients hold most of the mass and everything after them may be present only in trace amounts. Second, the total blend weight against the known clinical dose: if an ingredient with a multi-hundred-milligram trial dose appears anywhere but first in a blend whose total weight is, say, 500 mg, it cannot be present at an effective amount. When the math is impossible, the marketing is the only thing at full strength.
What third-party certification adds, and the one fair exception
Independent certification programs such as USP Verified and NSF Certified for Sport require manufacturers to disclose and substantiate ingredient identity and quantity, which is fundamentally incompatible with hiding doses inside an opaque blend; a seal from one of these programs is therefore a meaningful signal that marketing copy is not. The fair exception is the standardized, trademarked extract—products built around a clinically studied branded extract such as KSM-66 ashwagandha typically disclose the extract's dose and treat the trade name as a single, transparent ingredient. That is a legitimate way to protect a formulation; it is the opposite of the ten-ingredient "matrix" whose only purpose is to keep individual doses off the label. Curcumin and other botanicals with branded, bioavailability-enhanced forms follow the same transparent pattern when used honestly.
Sources
- U.S. Food and Drug Administration. "Code of Federal Regulations Title 21, Section 101.36 — Nutrition labeling of dietary supplements." ecfr.gov.
- Kreider RB, Kalman DS, Antonio J, et al. "International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine." Journal of the International Society of Sports Nutrition, 2017;14:18. PMID 28615996.
- da Costa BRB, El Haddad LP, Freitas BT, Marinho PA, De Martinis BS. "Pre-workout supplements marketed in Brazil: Caffeine quantification and caffeine daily intake assessment." Drug Testing and Analysis, 2021;14(3):567-577. PMID 33835708.
- Cohen PA, Travis JC, Keizers PHJ, Deuster P, Venhuis BJ. "Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA)." Clinical Toxicology, 2018;56(6):421-426. PMID 29115866.
- U.S. Pharmacopeia. "USP Verified Dietary Supplements — verification program requirements." usp.org.